Children conceived by assisted reproductive technology (ART) do not appear to have a significantly increased cancer risk.
Women with infertility-treated pregnancy have an increased risk for severe maternal morbidity or maternal death, with invasive infertility treatment associated with an increased likelihood of having three or more severe maternal morbidity indicators.
Children born by medically assisted reproduction have an increased risk for adverse birth outcomes; however, the increased risk appears to be attributable to other factors.
The expanded approval was based on safety and efficacy data from a confirmatory Phase 3 randomized, double-blind, placebo-controlled multicenter study evaluating Osphena in patients with moderate to severe vaginal dryness.
Higher mindfulness and lower stress are independently associated with lower menopausal symptom scores among midlife women.
Initiation and continuation trends in menopausal hormone therapy may have been influenced by the premature cessation of the 2002 Women’s Health Initiative trial, which was halted due to safety concerns.
For women undergoing in vitro fertilization (IVF), endometrial scratching by pipelle biopsy between day 3 of the cycle preceding the embryo-transfer cycle and day 3 of the embryo-transfer cycle, does not result in a higher rate of live birth.
Hormone therapy in postmenopausal women may be protective against knee OA.
Researchers observed that sleep disturbances may be more prevalent in women with polycystic ovary syndrome.
Researchers sought to determine whether behavioral modification intervention could help improve reproductive function in women with obesity with polycystic ovary syndrome even when their weight loss is minimum.
Preconception hyperandrogenism and impaired glucose tolerance are predictive of multiple obstetric and perinatal complications in women with PCOS.